Cargando…
Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction
Cardiovascular complications are the most prevalent cause of morbidity and mortality in diabetic patients. Metformin is currently the first-line blood glucose-lowering agent with potential relevance to cardiovascular diseases. However, the underpinning mechanisms of action remain elusive. Here, we r...
Autores principales: | Loi, Halyna, Boal, Frederic, Tronchere, Helene, Cinato, Mathieu, Kramar, Solomiia, Oleshchuk, Oleksandra, Korda, Mykhaylo, Kunduzova, Oksana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400884/ https://www.ncbi.nlm.nih.gov/pubmed/30873028 http://dx.doi.org/10.3389/fphar.2019.00154 |
Ejemplares similares
-
Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice
por: Loi, Halyna, et al.
Publicado: (2021) -
Galanin Regulates Myocardial Mitochondrial ROS Homeostasis and Hypertrophic Remodeling Through GalR2
por: Boal, Frederic, et al.
Publicado: (2022) -
Galanin promotes autophagy and alleviates apoptosis in the hypertrophied heart through FoxO1 pathway
por: Martinelli, Ilenia, et al.
Publicado: (2021) -
Differential protein profiling as a potential multi-marker approach for obese patients with heart failure: A retrospective study
por: Timotin, Andrei, et al.
Publicado: (2018) -
Inhibition of PIKfyve prevents myocardial apoptosis and hypertrophy through activation of SIRT3 in obese mice
por: Tronchere, Helene, et al.
Publicado: (2017)